TnP Peptide Suppresses Experimental Autoimmune Encephalomyelitis (EAE) in a Preclinical Mouse Model

TnP is a family of patented synthetic peptides which is in a preclinical development stage with valuable potential therapeutic indication for multiple sclerosis (MS), an autoimmune demyelinating disease of the central nervous system (CNS). The use of a preclinical animal model, such as experimental...

Descripción completa

Detalles Bibliográficos
Autores principales: Lima, Carla, Maleski, Adolfo Luis Almeida, Bernardo, Jefferson Thiago Gonçalves, Zelli, Vitor Cataldi, Komegae, Evilin Naname, Lopes-Ferreira, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988151/
https://www.ncbi.nlm.nih.gov/pubmed/35401524
http://dx.doi.org/10.3389/fimmu.2022.857692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988151/
https://www.ncbi.nlm.nih.gov/pubmed/35401524
http://dx.doi.org/10.3389/fimmu.2022.857692

Ejemplares similares